Zai Lab Limited (ZLAB)
NASDAQ: ZLAB · Real-Time Price · USD
22.77
+0.89 (4.07%)
At close: Apr 24, 2026, 4:00 PM EDT
22.57
-0.20 (-0.88%)
After-hours: Apr 24, 2026, 4:59 PM EDT
Zai Lab Revenue
In the year 2025, Zai Lab had annual revenue of $460.16M with 15.33% growth. Zai Lab had revenue of $127.60M in the quarter ending December 31, 2025, with 16.99% growth.
Revenue (ttm)
$460.16M
Revenue Growth
+15.33%
P/S Ratio
5.56
Revenue / Employee
$257,935
Employees
1,784
Market Cap
2.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 460.16M | 61.17M | 15.33% |
| Dec 31, 2024 | 398.99M | 132.27M | 49.59% |
| Dec 31, 2023 | 266.72M | 51.68M | 24.03% |
| Dec 31, 2022 | 215.04M | 70.73M | 49.01% |
| Dec 31, 2021 | 144.31M | 95.35M | 194.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADMA Biologics | 510.17M |
| Tarsus Pharmaceuticals | 451.36M |
| IDEAYA Biosciences | 218.71M |
| Soleno Therapeutics | 190.41M |
| Beam Therapeutics | 139.74M |
| Immunome | 6.94M |
| Celldex Therapeutics | 1.55M |
ZLAB News
- 4 days ago - Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026 - Business Wire
- 6 days ago - Zai Lab Transcript: Study update - Transcripts
- 6 days ago - ZLAB: Zai Lab Unveils Promising Data for ZL-1503 in Treating Atopic Diseases - GuruFocus
- 8 days ago - Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases - Business Wire
- 8 days ago - ZLAB: Zai Lab Showcases Promising Clinical Data for Cancer Treatment - GuruFocus
- 8 days ago - Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas - Business Wire
- 11 days ago - Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas - GlobeNewsWire
- 25 days ago - Zai Lab Stock Gains 8% Over Clinical Trial Collaboration With Amgen - Nasdaq